Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Associations and mediating mechanisms between lung cancer and chronic comorbidities: a matched case-control study
Yuan Sheng1, Kai Di1, Yuzhao Liu2
1School of Nursing and Rehabilitation, Shandong University, Jinan, China.
Background:
Respiratory and cardio-cerebrovascular comorbidities are common in patients with lung cancer (LC), yet their clinical correlates and potential mediating mechanisms remain poorly understood.
Objectives:
This study investigates the associations between respiratory and cardio-cerebrovascular comorbidities and LC and explores subtype-specific tumor biomarkers.
Methods:
A 1:1 matched case-control study was conducted at Qilu Hospital of Shandong University from April 2023 to March 2024. Conditional logistic regression models, adjusted for potential confounders, and causal mediation analysis were used to assess the associations and mediating pathways between chronic comorbidities and LC, including subtype-specific tumor biomarkers. Comorbidity data and blood biomarkers were extracted from electronic medical records.
Results:
Respiratory and cardio-cerebrovascular comorbidities were significantly associated with LC (model 4: p = 0.029 and p = 0.045). After adjustment for the total number of chronic comorbidities, these associations were no longer significant (model 5: p = 0.507 and p = 0.875). Lymphocyte percentage (Lym %) and d-dimer (DDi) partially mediated both associations (single-mediator models: all p < 0.05). CYFRA21-1 was linked to respiratory comorbidities (p = 0.001), whereas PRO-GRP was associated with cardio-cerebrovascular comorbidities (p = 0.031), indicating subtype-specific patterns related to non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC).
Conclusions:
LC is associated with both respiratory and cardio-cerebrovascular comorbidities, and immune- and coagulation-related biomarkers may partially mediate these associations. Total comorbidity burden shows a stronger association with LC risk than any individual comorbidity, underscoring the value of incorporating comorbidity assessment into LC risk evaluation.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Statistical Methods for Analyzing Epidemiological Data
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

